Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,086 | 141,003 | 108,520 | 121,510 | 226,102 |
| Receivables | 37,887 | 51,563 | 51,070 | 56,939 | 44,691 |
| Inventories | 98,666 | 83,343 | 107,789 | 134,608 | 136,643 |
| Other current assets | 19,909 | 2,228 | 4,291 | 3,569 | 3,654 |
| TOTAL | $259,273 | $294,257 | $278,087 | $326,046 | $421,755 |
| Non-Current Assets | |||||
| PPE Net | 327,192 | 344,846 | 368,308 | 379,722 | 369,092 |
| Investments And Advances | 0 | 0 | 0 | 1,228 | 5,912 |
| Intangibles | 483,515 | 577,478 | 576,663 | 738,145 | 884,411 |
| Other Non-Current Assets | 127,320 | 138,774 | 135,409 | 138,551 | 99,293 |
| TOTAL | $938,027 | $1,061,098 | $1,080,380 | $1,257,646 | $1,358,708 |
| Total Assets | $1,197,300 | $1,355,355 | $1,358,467 | $1,583,692 | $1,780,463 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,784 | 11,934 | 11,817 | 10,976 | 19,928 |
| Accounts payable and accrued liabilities | 16,540 | 13,651 | 27,587 | 28,093 | 32,278 |
| Accrued Expenses | 58,017 | 54,296 | 69,079 | 65,161 | 95,442 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,172 |
| TOTAL | $100,180 | $94,338 | $200,242 | $255,865 | $288,394 |
| Non-Current Liabilities | |||||
| Long Term Debt | 417,095 | 460,750 | 497,713 | 476,891 | 465,079 |
| Deferred Revenues | 2,566 | 2,486 | N/A | 47,834 | 71,833 |
| Other Non-Current Liabilities | 374,456 | 331,395 | 25,930 | 10,796 | -15,762 |
| TOTAL | $844,618 | $872,841 | $730,158 | $740,144 | $694,333 |
| Total Liabilities | $944,798 | $967,179 | $930,400 | $996,009 | $982,727 |
| Shareholders' Equity | |||||
| Common Shares | 1,722,277 | 1,706,822 | 1,689,452 | 1,617,093 | 1,597,715 |
| Retained earnings | -1,500,244 | -1,352,486 | -1,265,536 | -1,076,198 | -841,907 |
| Other shareholders' equity | -89,578 | -88,910 | -78,776 | -40,749 | 41,928 |
| TOTAL | $252,502 | $388,176 | $428,067 | $587,683 | $797,736 |
| Total Liabilities And Equity | $1,197,300 | $1,355,355 | $1,358,467 | $1,583,692 | $1,780,463 |